Thymidine phosphorylase/platelet-derived endothelial cell growth factor (PD-ECGF) associated with prognosis in renal cell carcinoma

Urological Research

Volumn 29, Issue 1, 2001, Pages 7-12

  Suzuki, K ^a   Morita, T ^a   Hashimoto, S ^a   Tokue, A ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Microvessel density; Prognosis; Renal arteriography; Renal cell carcinoma; Thymidine phosphorylase

Indexed keywords

PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; THYMIDINE PHOSPHORYLASE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER SURVIVAL; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY ARTERIOGRAPHY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR GROWTH;

ADULT; AGED; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RENAL CIRCULATION; SURVIVAL ANALYSIS; THYMIDINE PHOSPHORYLASE;

EID: 0035107685     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002400000154     Document Type: Article

References (40)

1. Angiogenesis and expression of platelet-derived endothelial cell growth factor in oral squamous cell carcinoma
2. Clinical comparison between vascular and avascular renal cell carcinoma
3. Chromophobe cell renal carcinoma: Clinicopathological features of 50 cases
4. Are angiogenic factors, cytokines and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
5. Enhancement of 5-fluorouracil cytotoxicity by human thymidine-phosphorylase expression in cancer cells: In vitro and in vivo study
6. What is the evidence that tumors are angiogenesis dependent?
7. Angiogenic factor
8. Members of the Cancer Incidence and End Results Committee (1995) Renal cell carcinoma: Tumor size, stage and survival
9. Angiogenic activity of enzymes
10. Immunochemotherapy of metastatic renal cell carcinoma with interleukin-2, interferon-alpha and 5-fluorouracil
11. Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma
12. Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts
13. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer
14. Platelet-derived endothelial cell growth factor expression correlates with tumor angiogenesis and prognosis in non-small-cell lung cancer
15. Arteriographic assessment and staging of renal-cell carcinoma. Analysis of a series of 120 patients
16. Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma
17. Renal cell carcinoma: Prognostic significance of morphologic parameters in 121 cases
18. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue
19. Purification and properties of an endothelial cell growth factor from human platelets
20. Expression of platelet-derived endothelial cell growth factor in bladder carcinoma
21. Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity
22. Biomodulation of 5-fluorouracil by interferon-ain human renal cell carcinoma cells: Relationship to the expression of thymidine phosphorylase
23. Expression of basic fibroblast growth factor in primary human renal tumors: Correlation with poor survival
24. Clinical significance of tumor angiogenesis in patients with localized renal cell carcinoma
25. Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues
26. Prognostic factors in renal carcinoma. An evaluation of operative findings
27. Renal cell carcinoma: Prognostic Factors
28. Expression of platelet-derived endothelial cell growth factor correlates with good prognosis in patients with colorectal carcinoma
29. Tumor angiogenesis as a prognostic factor in ovarian carcinoma. Quantification of endothelial immunoreactivity by image analysis
30. Classic and modern prognostic indicators in renal cell carcinoma. Review of the literature
31. Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor
32. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis
33. The activity and expression of thymidine phosphorylase in human solid tumours
34. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer
35. Microvessel quantification and its possible relation with liver metastasis in colorectal cancer
36. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia
37. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma
38. Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma
39. Prognostic significance of microvessel count in low stage renal cell carcinoma